DDHD2 Gene SPG54 Genetic Test
Components: DDHD2 Gene SPG54 Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for DDHD2 Gene SPG54 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DDHD2 Gene SPG54
Test Details
The DDHD2 gene is associated with a rare genetic disorder called hereditary spastic paraplegia type 54 (SPG54). SPG54 is characterized by progressive muscle weakness and stiffness in the lower limbs, leading to difficulty walking. Other symptoms may include muscle wasting, spasticity, and impaired coordination.
NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, allowing for the identification of genetic variations associated with certain conditions. In the case of SPG54, NGS genetic testing can be used to detect mutations in the DDHD2 gene, which can help confirm a diagnosis.
NGS genetic testing typically involves obtaining a DNA sample from the individual being tested, usually through a blood sample or cheek swab. The DNA is then sequenced, and the resulting data is analyzed to identify any genetic variations or mutations in the DDHD2 gene.
The results of the NGS genetic test can provide valuable information for individuals suspected of having SPG54, as it can confirm the presence of mutations in the DDHD2 gene. This can help guide treatment decisions and provide information about the inheritance pattern of the condition.
It is important to note that genetic testing should always be done under the guidance of a healthcare professional or genetic counselor who can help interpret the results and provide appropriate counseling and support.
| Test Name | DDHD2 Gene SPG54 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for DDHD2 Gene SPG54 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DDHD2 Gene SPG54 |
| Test Details |
The DDHD2 gene is associated with a rare genetic disorder called hereditary spastic paraplegia type 54 (SPG54). SPG54 is characterized by progressive muscle weakness and stiffness in the lower limbs, leading to difficulty walking. Other symptoms may include muscle wasting, spasticity, and impaired coordination. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, allowing for the identification of genetic variations associated with certain conditions. In the case of SPG54, NGS genetic testing can be used to detect mutations in the DDHD2 gene, which can help confirm a diagnosis. NGS genetic testing typically involves obtaining a DNA sample from the individual being tested, usually through a blood sample or cheek swab. The DNA is then sequenced, and the resulting data is analyzed to identify any genetic variations or mutations in the DDHD2 gene. The results of the NGS genetic test can provide valuable information for individuals suspected of having SPG54, as it can confirm the presence of mutations in the DDHD2 gene. This can help guide treatment decisions and provide information about the inheritance pattern of the condition. It is important to note that genetic testing should always be done under the guidance of a healthcare professional or genetic counselor who can help interpret the results and provide appropriate counseling and support. |
